Is Intermediate-Dose Cytarabine a Good Control for Patients with Relapsed or Refractory Acute Myeloid Leukemia?

被引：2
|
作者：
Bertoli, Sarah [1 ]
Gadaud, Noemie [2 ]
Tavitian, Suzanne [1 ]
Sarry, Audrey [1 ]
Berard, Emilie [3 ,4 ]
Huguet, Francoise [1 ]
Recher, Christian [1 ,5 ]
机构：
[1] CHU Toulouse, Inst Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France
[2] Inst Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France
[3] CHU Toulouse, Serv Epidemiol, Toulouse, France
[4] Univ Toulouse 3, INSERM, UMR 1027, Toulouse, France
[5] CNRS, ERL5294, INSERM, UMR1037,Ctr Rech Cancerol Toulouse, Toulouse, France
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3991.3991
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3991
引用
收藏
页数：5
相关论文
共 50 条
  • [21] HIGH-DOSE VERSUS INTERMEDIATE-DOSE CYTARABINE COMBINED WITH MITOXANTRONE FOR THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA - RESULTS OF AN AGE-ADJUSTED RANDOMIZED COMPARISON
    HIDDEMANN, W
    AUL, C
    MASCHMEYER, G
    SCHONROCKNABULSI, R
    LUDWIG, WD
    BARTHOLOMAUS, A
    BETTELHEIM, P
    BECKER, K
    BALLEISEN, L
    LATHAN, B
    KOPPLER, H
    GRUNEISEN, T
    DONHUIJSENANT, R
    REICHLE, A
    BUCHNER, T
    SEMINARS IN HEMATOLOGY, 1991, 28 (03) : 35 - 38
  • [22] Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia
    Reman, O
    Buzyn, A
    Lhéritier, V
    Huguet, F
    Kuentz, M
    Stamatoullas, A
    Delannoy, A
    Fegueux, N
    Micléa, JM
    Boiron, JM
    Vernant, JP
    Gardin, C
    Hacini, M
    Georges, M
    Fière, D
    Thomas, X
    HEMATOLOGY JOURNAL, 2004, 5 (02) : 123 - 129
  • [23] Induction and consolidation therapy with intermediate-dose cytarabine, mitoxantrone and etoposide in patients >=60 years with acute myeloid leukemia (AML).
    Shepherd, JD
    Barnett, MJ
    Brockington, DA
    Fung, HC
    Klingemann, HG
    Nantel, SH
    Reece, DE
    Sutherland, HJ
    Thierman, JG
    Toze, CL
    Phillips, GL
    BLOOD, 1995, 86 (10) : 2075 - 2075
  • [24] SEQUENTIAL INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE FOR PATIENTS WITH RELAPSED AND REFRACTORY ACUTE MYELOCYTIC-LEUKEMIA
    PACIUCCI, PA
    CUTTNER, J
    HOLLAND, JF
    AMERICAN JOURNAL OF HEMATOLOGY, 1990, 35 (01) : 22 - 25
  • [25] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Dae Sik Kim
    Ka-Won Kang
    Se Ryeon Lee
    Yong Park
    Hwa Jung Sung
    Seok Jin Kim
    Chul Won Choi
    Byung Soo Kim
    Annals of Hematology, 2015, 94 : 1485 - 1492
  • [26] Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia
    Zhang, Wenjun
    Ding, Yi
    Wu, Hao
    Chen, Yuhua
    Lu, Huina
    Chen, Chunying
    Fu, Jianfei
    Wang, Weiguang
    Liang, Aibin
    Zou, Shanhua
    MEDICINE, 2014, 93 (27)
  • [27] EFFICACY OF ETOPOSIDE AND MITOXANTRONE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA REFRACTORY TO STANDARD INDUCTION THERAPY AND INTERMEDIATE-DOSE CYTARABINE WITH AMSIDINE
    DAENEN, S
    LOWENBERG, B
    SONNEVELD, P
    VANPUTTEN, WLJ
    VERHOEF, G
    VANVELDHOVEN, M
    HUIJGENS, PC
    LEUKEMIA, 1994, 8 (01) : 6 - 10
  • [28] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Kim, Dae Sik
    Kang, Ka-Won
    Lee, Se Ryeon
    Park, Yong
    Sung, Hwa Jung
    Kim, Seok Jin
    Choi, Chul Won
    Kim, Byung Soo
    ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1485 - 1492
  • [29] Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML)
    Ulf Schnetzke
    Peter Fix
    Baerbel Spies-Weisshart
    Karin Schrenk
    Anita Glaser
    Hans-Joerg Fricke
    Paul La Rosée
    Andreas Hochhaus
    Sebastian Scholl
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1391 - 1397
  • [30] Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML)
    Schnetzke, Ulf
    Fix, Peter
    Spies-Weisshart, Baerbel
    Schrenk, Karin
    Glaser, Anita
    Fricke, Hans-Joerg
    La Rosee, Paul
    Hochhaus, Andreas
    Scholl, Sebastian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (08) : 1391 - 1397
12345